Numerous studies have shown that the tumor suppressor LATS2 is downregulated in various carcinomas and that this protein impedes tumor proliferation and invasion, e.g., in GC [20], non-small cell lung cancer (NSCLC) [50, 51] and ovarian tumors [52]. This evidence concerns the gene LATS2 and carcinoma.